Health Protection Agency Centre for Infections, 61 Colindale Avenue, London, United Kingdom.
J Clin Microbiol. 2009 Oct;47(10):3301-7. doi: 10.1128/JCM.00969-09. Epub 2009 Aug 12.
Listeriosis is a rare but severe food-borne disease, affecting unborn or newly delivered infants, the elderly, and the immunocompromised. The epidemiology of listeriosis in England and Wales changed between 2001 and 2007, with more patients > or = 60 years old presenting with bacteremia (but without central nervous system [CNS] involvement). In order to explain this increase and understand the altered disease presentation, clinical, microbiological, and seasonal data on bacteremic cases of Listeria monocytogenes infection identified through national surveillance were compared with those for patients with CNS infections. Logistic regression analysis was applied while controlling for age. Bacteremic patients, who presented more frequently with gastrointestinal symptoms, were more likely to have underlying medical conditions than CNS patients. This was most marked in patients with malignancies, particularly digestive organ malignancies. Treatment to reduce stomach acid secretion modified the effect of nonmalignant underlying conditions on outcome, i.e., patients with an underlying condition who were not taking acid-suppressing medication were equally likely to have a bacteremic or a CNS infection. However, this type of therapy did not modify the effect of malignancies on the likelihood of having a bacteremic or a CNS infection. The increase in the incidence of human listeriosis among patients > or = 60 years old in England and Wales between 2001 and 2007 appears to have occurred in those with cancer or other conditions whose treatment included acid-suppressing medication. Therefore, this vulnerable patient group needs specific dietary advice on avoiding risk factors for listeriosis.
李斯特菌病是一种罕见但严重的食源性疾病,影响未出生或刚分娩的婴儿、老年人和免疫功能低下者。2001 年至 2007 年间,英格兰和威尔士的李斯特菌病流行病学发生了变化,更多的>或=60 岁患者出现菌血症(但无中枢神经系统[CNS]受累)。为了解释这种增加并了解改变的疾病表现,通过国家监测确定的李斯特菌感染菌血症病例的临床、微生物学和季节性数据与 CNS 感染患者进行了比较。在控制年龄的情况下应用了逻辑回归分析。表现出更频繁胃肠道症状的菌血症患者比 CNS 患者更有可能患有潜在的医疗条件。在患有恶性肿瘤的患者中,这种情况最为明显,尤其是消化器官恶性肿瘤患者。减少胃酸分泌的治疗方法改变了非恶性潜在疾病对结果的影响,即未服用抑酸药物的有潜在疾病的患者发生菌血症或 CNS 感染的可能性相同。然而,这种治疗方法并没有改变恶性肿瘤对发生菌血症或 CNS 感染的可能性的影响。2001 年至 2007 年间,英格兰和威尔士 60 岁以上人群李斯特菌病发病率的增加似乎发生在接受包括抑酸药物在内的治疗的癌症或其他疾病患者中。因此,这一脆弱的患者群体需要有关避免李斯特菌病危险因素的具体饮食建议。